Related Experiment Video
Updated: Feb 11, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
[Intradermal immunotherapy with low-dose house dust mite allergens in patients with allergic rhinitis: A
Alberto Vieira-Hernández1, Arnaldo Capriles-Hulett, Mario Sánchez-Borges
1Hospital Municipal de Caraballeda, Maiquetia, Venezuela. arnaldocapriles@gmail.com.
Background:
High-dose aqueous subcutaneous immunotherapy is a validated and effective administration route for house dust mite and pollen allergens.
Objective:
A proof-of-concept study using intradermal immunotherapy (IDIT) with low-dose house dust mite allergens (Dermatophagoides pteronyssinnus/Dermatophagoides farinae [Dp/Df] and Blomia tropicalis [Bt]) was carried out in children with allergic rhinitis symptomatic upon exposure to house dust.
Methods:
Eight immunotherapy-naïve patients with positive prick skin tests and specific serum IgE to a Dp/Df mixture and to Bt were weekly administered 0.05 mL of an IDIT consisting of a phenolyzed albumin-saline preparation containing low-dose dust mites (8.3 AU [5 ng] of Dp/Df and 2.5 DBU of Bt), for 3 months. Nasal (Total Nasal Symptom Score) and facial symptoms (Visual Analog Scale) were recorded 2 weeks prior to treatment and once weekly during its course. Serial dilutions skin prick tests (1/100-1/1.000.000) and serum allergen-specific IgG4 determinations were performed at baseline and at treatment conclusion.
Results:
Values on the scales suggested clinical improvement. There was a significant decrease in serial dilutions skin prick tests' wheal diameters, as well as an increase in serum IgG4 values at treatment completion. IDIT was well tolerated.
Conclusion:
If the present results are confirmed by further studies, allergen-specific immunotherapy wider use could be promoted.
More Related Videos
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
06:08Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Related Concept Videos
Allergic Reactions
Social Proof
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Tumor Immunotherapy
Bioavailability Study Design: Single Versus Multiple Dose Studies